14-109-937

CD109 Monoclonal Antibody (HU17), eBioscience™, Invitrogen™

Manufacturer: Invitrogen

Select a Size

Pack Size SKU Availability Price
Each of 1 14-109-937-Each-of-1 In Stock ₹ 1,22,108.00

14-109-937 - Each of 1

₹ 1,22,108.00

In Stock

Quantity

1

Base Price: ₹ 1,22,108.00

GST (18%): ₹ 21,979.44

Total Price: ₹ 1,44,087.44

Antigen

CD109

Classification

Monoclonal

Concentration

0.5 mg/mL

Formulation

PBS with 0.09% sodium azide; pH 7.2

Gene Accession No.

Q6YHK3

Gene Symbols

CD109

Purification Method

Affinity chromatography

Regulatory Status

RUO

Gene ID (Entrez)

135228

Content And Storage

4° C

Form

Liquid

Applications

Flow Cytometry, Immunoprecipitation

Clone

HU17

Conjugate

Unconjugated

Gene

CD109

Gene Alias

150 kDa TGF-beta-1-binding protein; 9930012E15Rik; activated T-cell marker CD109; AI480638; C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7; Cd109; CD109 antigen; CD109 molecule; CPAMD7; GARP; Gov platelet alloantigens; GPI-anchored alpha 2 macroglobulin-related protein; GPI-anchored alpha-2 macroglobulin-related protein; p180; platelet-specific Gov antigen; r150; RP11-525G3.1

Host Species

Mouse

Quantity

2 mg

Primary or Secondary

Primary

Target Species

Human

Product Type

Antibody

Isotype

IgG1 κ

Related Products

Img

Invitrogen

14-079-137

--

Img

Invitrogen

50-123-27

--

Img

Invitrogen

50-125-78

--

Img

Invitrogen

50-124-04

--

Img

Invitrogen

50-123-29

--

Img

Invitrogen

50-113-7060

--

Img

Invitrogen

14-318-937

--

Img

Invitrogen

14318982

--

Description

  • The HU17 MAb reacts with human CD109, also known as the platelet-specific Gov antigen
  • CD109, a GPI-anchored monomeric glycoprotein, exists in two isoforms of 120 and 150 kDa, which are proteolytically degraded from a 170 kDa form
  • CD109 is expressed on activated T cells, activated platelets and endothelial cells
  • CD109 expression is also found on a subset of CD34+ cells in adult and fetal bone marrow which contain megakaryocyte, myeloid, erythroid and multilineage progenitors, as well as pluriopotent hematopoietic stem cells
  • Recently, it has been demonstrated that CD109 is expressed on a variety of human cancer cell lines, and also lung and esophogeal cell carcinomas
  • In addition, CD109 was recently found to be a negative regulator of TGF-beta in keratinocytes
  • CD109 is a member of the alpha2-macroglobulin/complement superfamily
  • The encoded GPI-linked glycoprotein is found on the cell surface of platelets, activated T-cells, and endothelial cells
  • The protein binds to and negatively regulates signaling of transforming growth factor beta (TGF-beta).